MacroGenics wins FDA approval to sell its first product, Margenza – Washington Business Journal

By Super UserDecember 21, 2020News

Home » MacroGenics wins FDA approval to sell its first product, Margenza – Washington Business Journal

The 20-year-old company’s first product tackles certain breast cancers.

Image: Dr. Scott Koenig is president and CEO of Rockville biotech MacroGenics. JOANNE S. LAWTON

{iframe}https://www.bizjournals.com/washington/news/2020/12/16/macrogenics-wins-fda-approval-for-first-product.html{/iframe}